This result suggested that the IL-22 produced by the CTCL cells might activate the IL-22 receptor in these cells, leading to the activation of downstream targets and subsequently increasing the transcription of CCL20. However, we could not determine the downstream cascade of IL-22 that mediates CCL20 transcription activation. The gene discussed is IL22; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.